Mesothelioma Cancer Resources Blog

Amgen, a leading human therapeutics company in the biotechnology industry that  discovers, develops, manufactures, and delivers innovative human therapeutics, has announced that their investigational drug motesanib failed to improve overall survival among patients with non-small cell lung cancer (NSCLC) in a phase III trial.  The company had hoped that the promising drug would offer a …

The American Thoracic Society (ATS) has announced the dates for their annual International Symposium on pulmonary care.  Scheduled for May 13-18, 2011, the conference will be held in Denver, Colorado with the theme “Where today’s science meets tomorrow’s care in pulmonary, critical care and sleep medicine.”  The ATS conference will feature multiple sessions on bioengineering …

Researchers at Cancer Research UK have validated that a simple blood test to “count” the number of circulating tumor cells (CTCs) in a lung cancer patient can predict the patient’s survival.  In addition, the researchers concluded that by identifying CTCs in a lung cancer patient’s bloodstream undergoing treatment, oncologists can monitor the patient’s response and …

Amgen, a leading human therapeutics company in the biotechnology industry dedicated to helping people fight serious illness, has updated their Breakaway from Cancer website to provide cancer patients, survivors, and caregivers a ‘one-stop shop’ of essential cancer resources.  The site now includes their “cancer resource navigator” tool providing access to more than 100 leading cancer …

by Nancy Meredith Agennix AG, a Germany-based, biopharmaceutical company focused on the development of novel therapies for critically ill patients in areas of major unmet medical need, has announced that the United States Patent Office has issued them a patent for the use of talactoferrin to treat non-small cell lung cancer (NSCLC) and renal cell …

Asbestos is a carcinogen, which means that it is a substance that is known to cause cancer – both lung cancer and mesothelioma.  Breathing in asbestos dust results in microscopic fibers penetrating the lungs and damaging the healthy mesothelial cells.  In effect, asbestos damages DNA, the material within a cell that provides each person’s genetic …

Mesothelioma is a unique and rare form of cancer, typically affecting the lining of the lungs, caused by exposure to asbestos fibers.  Individuals primarily sickened with the asbestos-related disease were exposed to asbestos in the workplace, or through unsafe demolition or renovation practices of pre-1970 structures where asbestos was used in many of the construction …

In a recent study by scientists in Germany, researchers found that workers at power plants are among those at highest risk of workplace asbestos exposure and developing mesothelioma.  Asbestos is a known carcinogen and is proven to cause mesothelioma, a rare form of cancer typically affecting the lining of the lungs.  Previously, the primary workers …

When cancer metastasizes to the bones or when side effects from treatments cause thinning of bones and osteoporosis, mesothelioma and lung cancer patients’ may experience excruciating pain as well as bone breaks or fractures.  Patients undergoing treatment for pleural mesothelioma can experience bone loss, for example, when prescribed prednisone to help with shortness of breath …

by Nancy Meredith It seems that everywhere we turn we see another advertisement or commercial designed to bring attention to the plight of Americans that are faced with cancer each year.  Yet still, much of the general public remains unaware of the tragedy of mesothelioma, an asbestos-related cancer, or many of the other approximately 200 …